Neogenomics Inc
NEO· Nasdaq
NEONeogenomics Inc
Filed Jul 29, 2014 · 10-Q · 29 days after period end · 0001193125-14-283729
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Net Income | $274.00K | $273.00K | $551.00K | -$293.00K |
| EPS Diluted | $0.01 | $0.01 | $0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Jul 29, 2014 · 29 d after period end
